Skip to main content
    P

    P3 Health Partners Inc (PIIIW)

    Official site

    MEDICAL CARE FACILITIES • NASDAQ

    $0.01
    -0.00 (-5.00%)

    Last updated: Nov 16, 2026 at 4:00 PM ET

    P3 Health Partners Inc (PIIIW) Financials: Revenue, Profit and Cash Flow

    Updated Sep 30, 2026. Financial statements from company filings, amounts in US dollars.

    P3 Health Partners reported revenue of $1.46B for the fiscal year ended Dec 31, 2025, down 2.8% from the year before. That year, net income was -$147.95M with a net margin of -10.1%, operating cash flow was -$91.24M and free cash flow was -$91.32M. The quarter ended Sep 30, 2026 had revenue of $396.34M and net income of $15.62M.

    Revenue and Margins

    The operating margin was -18.5% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $87.70M, a compound annual rate of 49.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.46B-2.8%-9.9%-18.5%-10.1%
    Dec 2024$1.50B+18.5%100.0%-20.8%-9.1%
    Dec 2023$1.27B-99.7%100.0%-13.3%-4.6%
    Dec 2022$491.06BN/A100.0%-6.4%0.0%
    Dec 2020$491.06M+237.5%100.0%-5.8%-6.4%
    Dec 2019$145.48M+65.9%100.0%-27.2%-28.8%
    Dec 2018$87.70MN/A100.0%-56.7%-49.9%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2020Dec 2019Dec 2018
    Revenue$1.46B$1.50B$1.27B$491.06B$491.06M$145.48M$87.70M
    Cost of revenue$1.60B$1.56B$1.23B$1.14B$485.30M$141.03MN/A
    Gross profit-$144.32M$1.50B$1.27B$491.06B$491.06M$145.48M$87.70M
    Operating income-$270.30M-$312.60M-$167.93M-$31.41B-$28.59M-$39.54M-$49.71M
    Net income-$147.95M-$135.85M-$57.77M-$10.08M-$31.41M-$41.97M-$43.80M
    EBITDA-$181.86M-$197.76M-$81.07M-$31.41B-$28.08M-$39.04M-$49.37M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$396.34M$386.38M$386.39M$384.81M$345.25M$355.79M$373.23M$370.69M$362.12M$379.16M$388.49M$346.86M
    Gross profit$396.34M$86.00M$29.29M$384.81M-$24.54M$355.79M-$5.78M$370.69M$362.12M$13.99M-$15.11M-$42.45M
    Operating income$22.98M$41.23M$8.24M-$153.87M-$44.22M-$34.12M-$38.09M-$130.44M-$106.99M-$31.33M-$43.83M-$64.26M
    Net income$15.62M$7.44M$1.22M-$75.52M-$31.59M-$20.36M-$20.48M-$58.62M-$46.51M-$12.02M-$18.70M-$25.46M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $273.41M exceeded cash and equivalents by $248.40M. Shareholder equity was negative, at -$155.23M, as total liabilities of $796.88M exceeded total assets of $656.64M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$656.64M$783.42M$860.97M$876.74M$2.36B$106.44M$65.61MN/A
    Current assets$133.08M$184.14M$166.02M$100.69M$199.86M$90.88M$52.35MN/A
    Cash and equivalents$25.01M$38.82M$36.32M$18.46M$140.48M$36.26M$32.59MN/A
    Total liabilities$796.88M$633.89M$427.31M$354.08M$299.94M$236.65M$121.54MN/A
    Short-term debt$45.04M$65.00M$2.70M$1.60M$3.62M$2.26M$3.25MN/A
    Long-term debt$228.37M$89.82M$108.32M$94.42M$80.00M$45.39M$15.00MN/A
    Shareholder equity-$155.23M$75.94M$142.13M$5.85M$2.06B-$130.22M-$42.05MN/A
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$669.72M$654.39M$674.16M$656.64M$683.56M$731.59M$783.87M$783.42M$833.33M$892.76M$855.92M$860.97M
    Total liabilities$469.00M$581.20M$807.32M$796.88M$664.64M$644.41M$662.79M$633.89M$569.42M$527.93M$470.49M$427.31M
    Cash and equivalents$43.90M$21.27M$25.50M$25.01M$37.71M$38.58M$40.08M$38.82M$62.96M$73.09M$27.30M$36.32M
    Shareholder equity$107.27M$72.19M-$143.55M-$155.23M-$18.69M$44.46M$63.25M$75.94M$120.51M$166.84M$146.60M$142.13M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$91.24M-$110.13M-$76.03M-$126.02MN/A-$24.60M-$28.29M-$29.24M
    Capital expenditures$79.00K$0$1.83M$2.23M$0$2.93M$1.45M$3.31M
    Free cash flow-$91.32M-$110.13M-$77.86M-$128.25MN/A-$27.52M-$29.74M-$32.54M
    Dividends paidN/AN/AN/AN/AN/A$180.00KN/AN/A
    Investing cash flow$129.00K$14.53M-$1.83M-$7.73MN/A-$3.17M-$3.86M-$4.60M
    Financing cash flow$72.81M$98.77M$100.33M$11.38MN/A$34.76M$63.62M$33.25M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$685.00K-$61.91M-$27.47M-$25.73M-$15.41M-$16.63M-$33.47M-$57.24M-$22.62M-$10.24M-$20.03M-$15.88M
    Capital expenditures$0$0$0$198.00K$119.00K$0$0$0$0$0$0$212.00K
    Free cash flow-$685.00K-$61.91M-$27.47M-$25.93M-$15.53M-$16.63M-$33.47M-$57.24M-$22.62M-$10.24M-$20.03M-$16.09M
    Last 12 quarters

    Frequently Asked Questions About PIIIW

    What is P3 Health Partners' annual revenue?

    P3 Health Partners reported revenue of $1.46B for the fiscal year ended Dec 31, 2025.

    How fast is P3 Health Partners' revenue growing?

    Revenue was down 2.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -85.6%.

    Is P3 Health Partners profitable?

    No. P3 Health Partners reported net income of -$147.95M for the fiscal year ended Dec 31, 2025, with a net margin of -10.1%.

    How much free cash flow does PIIIW generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$91.24M minus capital expenditures of $79.00K produced free cash flow of -$91.32M.

    How much debt does P3 Health Partners have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $228.37M, short-term debt of $45.04M and cash and equivalents of $25.01M.